MUMBAI/NEW DELHI -- At least six Indian pharmaceutical companies have joined the global race to develop a novel coronavirus vaccine, giving a sector better known for making generic copies of drugs a platform to show its innovative capability.
Pharmaceuticals
Coronavirus tests India's vaccine makers in R&D capability
Top player Serum ties up with US company to target product launch by Q2 next year
Indian vaccine manufacturers have been able to offer affordable vaccines to developing countries because they have the capacity to mass-produce. (Source photo courtesy of Zydus Cadila)
Read Next
.JPG?width=178&fit=cover&gravity=faces&dpr=2&quality=medium&source=nar-cms&format=auto&height=100)
Latest on Pharmaceuticals
